Opendata, web and dolomites

ARFM

Automated Remote Foetal Monitoring

Total Cost €

0

EC-Contrib. €

0

Partnership

0

Views

0

 ARFM project word cloud

Explore the words cloud of the ARFM project. It provides you a very rough idea of what is the project "ARFM" about.

patient    disruptive    1968    women    infants    engineers    total    companies    creation    thanks    device    complementary    environment    ongoing    moves    showed    sequelae    remote    pregnancy    self    indirect    create    place    antenatal    costly    standard    foetal    monopolised    25    exceed    nearby    team    nateo    home    cardiotocographs    with    fhr    unsatisfactory    telemedicine    risk    market    though    safer    innovation    oelig    mother    million    care    direct    health    worldwide    died    heathcare    hundred    decided    pregnancies    ctg    observation    staff    50    hospitalisation    neonatal    born    answer    jobs    platform    2015    monitoring    public    heart    medical    grow    expert    data    70    acquisition    automated    ctgs    pregnant    turnover    expecting    leader    accelerates    difficult    2030    connected    urgent    first    position    obstetricians    patients    generate    prototype    issue    always    rate    reference    outcomes    tal    constituted    mobile    maternal    decrease    discrimination    deaths    healthcare    detection    multinational    imaging   

Project "ARFM" data sheet

The following table provides information about the project.

Coordinator
NATEO HEALTHCARE 

Organization address
address: 42 AVENUE DU GENERAL DE CROUTTE
city: TOULOUSE
postcode: 31100
website: n.a.

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.

 Coordinator Country France [FR]
 Project website http://www.nateo-healthcare.com/
 Total cost 71˙429 €
 EC max contribution 50˙000 € (70%)
 Programme 1. H2020-EU.3. (PRIORITY 'Societal challenges)
2. H2020-EU.2.3. (INDUSTRIAL LEADERSHIP - Innovation In SMEs)
3. H2020-EU.2.1. (INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies)
 Code Call H2020-SMEInst-2018-2020-1
 Funding Scheme SME-1
 Starting year 2019
 Duration (year-month-day) from 2019-02-01   to  2019-07-31

 Partnership

Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    NATEO HEALTHCARE FR (TOULOUSE) coordinator 50˙000.00

Map

Leaflet | Map data © OpenStreetMap contributors, CC-BY-SA, Imagery © Mapbox

 Project objective

With 2.7 million new-born infants and 0.3 million pregnant women who died in 2015 , making pregnancy safer is a public health priority worldwide, and in Europe in particular. It is estimated that 70% of neonatal deaths may be avoided . Even though, foetal monitoring with cardiotocographs (CTG) is the medical reference since 1968, it remains unsatisfactory with problems related to CTGs observed in 25% of foetal deaths. Moreover, antenatal hospitalisation for expecting mother considered to be “at-risk” is costly, and will grow with the increased number of at-risk pregnancies. There is an urgent medical need to improve foetal monitoring while addressing healthcare cost issue, but cardiotocographs has showed no major innovation since its creation in the 60’s. CTGs are still difficult to place for some patients, not always reliable (especially in case of foetal moves), and require medical staff nearby for data acquisition. To answer to this unsatisfactory observation, a complementary team constituted of obstetricians, medical imaging engineers and an expert in innovation decided to create Nateo Healthcare and develop a disruptive CTG. Nateo Healthcare’s CTG will be the first CTG allowing patient self-monitoring at home with a high standard of care, thanks to an automated detection of foetal heart rate (FHR), a discrimination of FHR from maternal environment, a mobile and connected device, associated to a telemedicine platform. Fœtal well-being monitoring will be improved, enhancing neonatal outcomes (deaths, sequelae). At-home monitoring will also generate a 50% decrease of healthcare cost related to at-risk pregnancies. With a prototype ongoing, Nateo Healthcare now accelerates its development to reach the market quickly, in a market monopolised by multinational companies, and achieve a leader position in remote monitoring for pregnancy. Nateo Heathcare’s total turnover is expected to exceed 100 M € by 2030 and to create several hundred of direct and indirect jobs.

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "ARFM" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "ARFM" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.3.;H2020-EU.2.3.;H2020-EU.2.1.)

IMPACT (2019)

Improving DNA Analysis for Correct Healthcare

Read More  

EASY-Diabetes (2019)

Individualised and Equitable Care of Type 2 Diabetes

Read More  

RDNA (2019)

Empowering New Venture Growth - RDNA

Read More